Clinical Trials Directory

Trials / Unknown

UnknownNCT03598543

Epidemiology of Klebsiella Pneumoniae in China

Klebsiella Pneumoniae Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sir Run Run Shaw Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Klebsiella pneumoniae is one of the most common pathogens causing both community-onset and nosocomial infection. More worse, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics,outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.

Detailed description

All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, outcome and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention, this is an obervational study.

Timeline

Start date
2018-06-01
Primary completion
2018-10-31
Completion
2018-12-31
First posted
2018-07-26
Last updated
2018-07-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03598543. Inclusion in this directory is not an endorsement.